2025-522261-30-00CompletedPhase 1/2
Evaluation of long-term safety in parkinsonian patients with intracerebroventricular administration of A-dopamine (anaerobic dopamine) - (DIVE-Follow up)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Aug 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- First submitted
- 20 Jun 2025
- Start date
- 1 Oct 2025
- Lead sponsor
- Centre Hospitalier Universitaire De Lille
- Diseases
- Parkinson disease
- EU CT number
- 2025-522261-30-00
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 2
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire De Lille | Lille Cedex | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.